Who is sponsoring NCT03393637?

NCT03393637 is sponsored by University of the Incarnate Word.

What drugs are being tested in NCT03393637?

Interventions in NCT03393637: Mentors Offering Maternal Support (M-O-M-S).

What condition does NCT03393637 study?

NCT03393637 studies Anxiety Fear, Prenatal Depression, Infant, Low Birth Weight, Preterm Birth, Maternal.

Is NCT03393637 still recruiting?

NCT03393637 is currently completed. Last updated 1 September 2022.

Last reviewed 2022-09-01 · How we verify

NCT03393637: M-O-M-S

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

Completed NA Last updated 1 September 2022

What this trial tests

NA trial testing Mentors Offering Maternal Support (M-O-M-S) in Anxiety Fear in 1,717 participants. Completed in 15 March 2022.

Timeline

1 December 2017

Primary endpoint
15 March 2022

15 March 2022

Quick facts

Lead sponsor	University of the Incarnate Word
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1,717
Start date	1 December 2017
Primary completion	15 March 2022
Estimated completion	15 March 2022
Sites	3 locations across United States

Drugs / interventions tested

Mentors Offering Maternal Support (M-O-M-S)

Conditions studied

Anxiety Fear — all drugs for Anxiety Fear →
Prenatal Depression — all drugs for Prenatal Depression →
Infant, Low Birth Weight — all drugs for Infant, Low Birth Weight →
Preterm Birth — all drugs for Preterm Birth →

Sponsor

University of the Incarnate Word

Who can join

18 and older, female only, with Anxiety Fear or Prenatal Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The M-O-M-S project evaluates the effectiveness of the M-O-M-S program for improving birth outcomes and maternal-infant attachment and role satisfaction in a large military sample.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interventions for fear of childbirth including tocophobia.
O'Connell MA, Khashan AS, Leahy-Warren P, Stewart F, et al · · 2021 · cited 39× · PMID 34231203 · DOI 10.1002/14651858.cd013321.pub2

Verify or expand the search:

Other University of the Incarnate Word trials

Trials by the same sponsor.

NCT05713981 — The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression · NA · completed
NCT05482997 — Athlete Whey Protein Sensitivity: Prevalence and Performance · NA · completed
NCT05990036 — The Outcome of Sports Vision Training on Collegiate Softball Players · NA · completed
NCT05463016 — Impact of Color Correcting Lenses on Color Vision Deficiency · NA · completed
NCT04808869 — Effectiveness of Blood Flow Restriction During Aerobic Cycling · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03393637 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of the Incarnate Word
Last refreshed: 1 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03393637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing